Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Entheon Biomedical Corp C.ENBI

Alternate Symbol(s):  ENTBF

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:ENBI)

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

GlobeNewswire December 7, 2022

Entheon (CSE:ENBI) closes sale of DMT clinical assets

John Ballem  July 11, 2022

Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets

Newsfile July 11, 2022

Entheon (CSE:ENBI) sells DMT clinical assets and files provisional patents

Azuka Onwuka June 7, 2022

Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents

Newsfile June 7, 2022

Ehave subsidiary partners with Entheon Biomedical (CSE:ENBI) in psychedelics research

Azuka Onwuka June 1, 2022

Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research

GlobeNewswire June 1, 2022

Entheon Biomedical (CSE:ENBI) announces $3M non-brokered private placement

John Ballem  April 5, 2022

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Newsfile April 5, 2022
View More News ››

Opinion & Analysis (CSE:ENBI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:ENBI)

reverse split

another one bites the dust. 
jerryfurberules - March 18, 2024

Update

Anyone know if Entheon is still in business? Web site is gone. I did call 3 numbers in Vancouver listed on line and 2 of the numbers were...
Tslayer - December 1, 2023

Oh oh

website now gone.
jerryfurberules - December 19, 2022

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1...
Betteryear2 - February 27, 2022

Excellent YT analysis on Entheon Biomed

https://youtu.be/6MmeuwtsCqo
BryceCanada - November 8, 2021

Progress

Patient recruitment in progress, steady as she goes! The benifits and personal statements of success in the news.
jerryfurberules - October 29, 2021
View more Bullboard ››

Western Metallica Resources Corp.

Western Metallica Resources Corp.

Western Metallica Resources Corp. is a Canada-based mineral exploration company with five mineral assets across Peru and ...
View More »